Anti-TNFs.
| Published in: | Gastroenterology & Hepatology Vol. 18; pp. 4 - 5 |
|---|---|
| Main Author: | |
| Format: | tables/charts Journal Article |
| Published: |
Gastro-Hep Communications, Inc
2022 Supplement
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=161114364&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 161114364 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15547914 6N5B jtl: Gastroenterology & Hepatology issn: 15547914 maglogo: N pubinfo: dt: 2022 Supplement vid: 18 pid: 72163 pub: Gastro-Hep Communications, Inc place: New York, New York artinfo: ui: 161114364 161114364 161114364 161114364 ppf: 4 ppct: 1 formats: fmt: @attributes: type: P tig: atl: Anti-TNFs. aug: au: Lichtenstein, Gary R. affil: Professor of Medicine, Director, Center for Inflammatory Bowel Disease, University of Pennsylvania Health System, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania sug: subj: Tumor Necrosis Factor Inhibitors Therapeutic Use Colitis, Ulcerative Drug Therapy Crohn Disease Drug Therapy Infliximab Therapeutic Use Drug Efficacy Biological Markers Disease Remission Recurrence Prevention and Control C-Reactive Protein Blood Antigens, Surface Analysis pubtype: Academic Journal doctype: tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|